论文部分内容阅读
目的:观察氧驱动复方丹参注射液雾化吸入辅助治疗高原地区毛细支气管炎患儿的临床疗效。方法:将86例毛细支气管炎患儿随机分为复方丹参注射液治疗组和对照组,治疗组患儿在常规治疗的基础上雾化吸入复方丹参注射液;对照组患儿在常规治疗基础上雾化吸入α-糜蛋白酶,两组均为2次/天,疗程(3～5)天。比较两组在咳嗽消失、气喘缓解、哮鸣音消失及住院时间方面的差异。结果:治疗组在缓解气喘、咳嗽消失、肺部哮鸣音消失、缩短住院时间方面明显优于对照组,差异有显著性(P<0.05)。结论:复方丹参注射氧动液雾化吸入是临床辅助治疗高原毛细支气管炎患儿安全、有效的药物。
OBJECTIVE: To observe the clinical effect of aerosol-driven compound salvia miltiorrhiza injection in the treatment of children with bronchiolitis in plateau area. Methods: Eighty-six children with bronchiolitis were randomly divided into compound Salvia miltiorrhiza injection group and control group. The treatment group received nebulization of compound Salvia miltiorrhiza injection on the basis of routine treatment. On the basis of conventional treatment, Atomization of α-chymotrypsin, both groups were 2 times / day, treatment (3 ~ 5) days. The differences between the two groups in the disappearance of cough, the relief of asthma, the disappearance of wheeze, and length of stay were compared. Results: The treatment group was significantly better than the control group in relieving asthma, cough disappeared, disappearance of lung wheeze, shortening hospital stay, the difference was significant (P <0.05). Conclusion: Compound Salvia miltiorrhiza injection of aerodynamic fluid inhalation is a safe and effective drug in the clinical adjuvant treatment of children with plateau bronchiolitis.